Ovarian stimulation for assisted reproduction.
Regimens for ovarian stimulation that result in increased circulating follicle-stimulating hormone with low levels of luteinizing hormone produce adequate follicular growth and improved oocyte quality and cycle outcome. Recombinant follicle-stimulating hormone for subcutaneous use and antagonists of gonadotropin-releasing hormone promise to simplify ovarian stimulation in the future.
Meldrum
D R
DR
Center for Advanced Reproductive Care, Redondo Beach, California 90277, USA.
D005260:Female; D005306:Fertilization / Q000187:drug effects; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D006062:Gonadotropins / Q000494:pharmacology*; D006801:Humans; D007986:Luteinizing Hormone / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects; D010053:Ovary / Q000187:drug effects*; D011994:Recombinant Proteins; D012098:Reproduction / Q000187:drug effects*; D013268:Stimulation, Chemical
D006062:Gonadotropins; D011994:Recombinant Proteins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone